World Influenza Congress Europe 2011 is the most in depth Flu conference in Europe
The World Influenza Congress Europe is the annual vaccine conference for influenza candidate COMMERCIALISATION, REVENUE GENERATION AND MARKET SUPPLY. It also highlights policy and planning, influenza research & development, and stakeholder partnerships.
Register to attend the World Influenza Congress Europe »
Download the brochure »
Come to the World Influenza Congress 2011 and discover:
- The global perspective of governmental immunisation requirements
- The future perspectives of regulators from Europe and North America regarding the use of adjuvant and novel influenza vaccines
- The work being done to translate strain surveillance data into a rapid response
- The novel vaccine research and clinical approaches currently in the production pipeline
- The breakthrough advances and progression in the development of universal vaccines
- How to enhance effectiveness, efficiency and safety of your influenza treatment
You’ll come away with great new ideas to do better business.
Download the brochure »
Register for World Influenza Congress Europe 2011 »
Download Sponsorship Prospectus »
|
Hear from an elite speaker faculty including leading executives from:
- Novartis Vaccines & Diagnostics
- Abbott Biologicals
- Baxter Bioscience
- CSL Ltd
- Crucell
- Flugen
- Dynavax Technologies
- AVIR Green Hills Biotechnology
- Protein Sciences
- Microgen
- EpiVax
- ITS Innovation
- Vaxin Inc
- NanoPass Technologies
- Glide Pharma
- EpiConcept
- CDC
- EU Commission
- NIMR
- HPA
- EMA
- FDA
Download the brochure »
Register for World Influenza Congress Europe 2011 »
Email us now for more details »
|
The World Influenza Congress focuses on:
- The concerns regarding seasonal and pandemic influenza preparedness, global strain surveillance and vaccine uptake
- The changing regulatory landscape for influenza vaccines both in Europe and North America
- The most innovative companies driving the development of novel influenza technologies for seasonal, pandemic and universal vaccines
- How to improve vaccine effectiveness, efficiency and safety and the growing inclusion of adjuvants
- The future of influenza vaccine administrative mechanisms
If you need to know the latest innovations in these areas you must attend.
Register now »
|
 |
 |
 |
Who should attend:
- Big Pharma
- Biotechs
- Academia/Research
- Government/Regulators
- CMOs
- CROs
- Equipment Manufacturers
- Consultants
Register for World Influenza Congress Europe 2011 »
Download the brochure »
|
Who should sponsor:
- Pharmaceutical manufacturers
- Large / SME Biotech
- Contract Research Organisations
- Contract Manufacture Organisations
- Equipment Manufacturers /
- Technology Providers
- Investment Banks / Private Equity
- Consultants
Download Sponsorship Prospectus »
|
Download the 2011 Sales Prospectus TODAY |
©Terrapinn Holdings Ltd. MMX